LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $21,510 | -22.4% | 322 | 0.0% | 0.01% | -27.3% |
Q3 2022 | $27,727 | -3.2% | 322 | +0.3% | 0.01% | 0.0% |
Q2 2022 | $28,640 | -20.7% | 321 | 0.0% | 0.01% | -8.3% |
Q1 2022 | $36,109 | +10.3% | 321 | +51.4% | 0.01% | +9.1% |
Q4 2021 | $32,746 | -11.0% | 212 | -19.7% | 0.01% | -21.4% |
Q3 2021 | $36,780 | -54.3% | 264 | -9.9% | 0.01% | -73.6% |
Q3 2018 | $80,426 | +56.5% | 293 | +18.1% | 0.05% | +47.2% |
Q2 2018 | $51,378 | +25.4% | 248 | 0.0% | 0.04% | +24.1% |
Q1 2018 | $40,960 | +20.6% | 248 | 0.0% | 0.03% | +16.0% |
Q4 2017 | $33,959 | +0.6% | 248 | 0.0% | 0.02% | -3.8% |
Q3 2017 | $33,765 | +12.1% | 248 | 0.0% | 0.03% | +8.3% |
Q2 2017 | $30,107 | +37.4% | 248 | +19.8% | 0.02% | +33.3% |
Q1 2017 | $21,909 | +4.2% | 207 | 0.0% | 0.02% | -5.3% |
Q4 2016 | $21,033 | -0.4% | 207 | 0.0% | 0.02% | 0.0% |
Q3 2016 | $21,126 | -14.4% | 207 | 0.0% | 0.02% | -17.4% |
Q2 2016 | $24,689 | +11.4% | 207 | 0.0% | 0.02% | +9.5% |
Q1 2016 | $22,168 | – | 207 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |